Christopher Jewell

Professor
Robert E. Fischell Institute for Biomedical Devices/University of Maryland; Veterans Affairs MD Healthcare System/Department of Veterans Affairs, United States

Disclosure information not submitted.

Presentation(s):

• Regulation of antigen-specific response to peptide therapeutics is independent of distribution in lymph nodes

  Thursday, October 9, 2025
  2:15 PM - 2:30 PM PDT

• Lymph node therapeutics stop Type 1 Diabetes by promoting Rapamycin-dependent long-lived Treg populations

  Thursday, October 9, 2025
  3:45 PM - 4:00 PM PDT

• E14 - Microneedles designed to alter innate signaling in the skin promote selective immune tolerance and stop autoimmune disease

  Friday, October 10, 2025
  10:00 AM - 11:00 AM PDT

• O6 - Local delivery of immunotherapies via microneedles geographically controls localized disease outcomes

  Friday, October 10, 2025
  10:00 AM - 11:00 AM PDT

• O7 - Co-Localization of Lymph Node Therapeutics in Lymph Nodes Enhances T Cell Activation and Anti-Tumor Response

  Friday, October 10, 2025
  10:00 AM - 11:00 AM PDT

• N31 - Microneedle array delivery of tolerizing immune cues to skin for countering autoimmunity

  Friday, October 10, 2025
  10:00 AM - 11:00 AM PDT

• C13 - Design and synthesis of itaconate polyesters enables metabolite delivery via microparticles that drive anti-inflammatory outcomes

  Friday, October 10, 2025
  10:00 AM - 11:00 AM PDT

• X40 - Covalent Cross-linking Enhances Stability and Retains Functionality of Immune Polyelectrolyte Multilayers

  Friday, October 10, 2025
  10:00 AM - 11:00 AM PDT

• Biodistribution of self-antigens and regulatory cues in lymph nodes induce memory-like Treg to drive antigen-specific tolerance

  Saturday, October 11, 2025
  9:00 AM - 9:15 AM PDT

• Rational control of toll-like receptor signaling using microneedles for enhanced vaccination

  Saturday, October 11, 2025
  9:30 AM - 9:45 AM PDT

• Biomaterials for Immunoengineering II

  Saturday, October 11, 2025
  2:30 PM - 4:00 PM PDT

• Lymph node depots control T cell fate to safely and durably reverse myelin-driven autoimmunity

  Saturday, October 11, 2025
  3:00 PM - 3:15 PM PDT